Nyu Langone Health
Clinical trials sponsored by Nyu Langone Health, explained in plain language.
-
New combo therapy aims to shrink throat tumors before standard treatment
Disease control Not yet recruitingThis study tests a new type of radiation (lattice radiotherapy) combined with chemotherapy and immunotherapy before standard chemoradiation for people with oropharyngeal cancer. About 60 participants will receive this induction therapy, and their tumor shrinkage will determine if…
Phase: PHASE1, PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
New program aims to restore intimacy and bladder control after prostate cancer
Symptom relief Not yet recruitingThis study tests a team-based program to help prostate cancer survivors with sexual and urinary problems. Two hundred adults who have been treated for prostate cancer will either get this special care or standard care. The program includes a care manager, nurse, and doctors worki…
Phase: NA • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
New gel may let prostate patients go home same day
Symptom relief Not yet recruitingThis study tests a gel called PuraStat to see if it can reduce bleeding after a prostate procedure called Aquablation. The goal is to help patients go home the same day instead of staying overnight. About 25 men with an enlarged prostate will take part.
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated May 11, 2026 20:38 UTC